What is the ticker symbol for Cerus?

Cerus trades under the ticker CERS on NASDAQ.

What sector does Cerus operate in?

Cerus is classified in the Healthcare sector (Medical - Devices industry).

How can PortView help analyze CERS in a portfolio?

PortView shows CERS's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Cerus (CERS) Stock Analysis

NASDAQHealthcareMedical - Devices

$2.59-0.69%

1-year price historyRange $1.18 – $3.28

52-week range$2.59

$1.17$3.47

What Cerus does

Cerus Corporation operates as a biotechnology firm dedicated to advancing and marketing the INTERCEPT Blood System. This proprietary technology significantly enhances the safety of transfusable blood components by neutralizing biological threats, thereby reducing the risk of blood-borne pathogens. The company's product line includes INTERCEPT systems specifically engineered to deactivate pathogens in donated platelets and plasma. It also offers a dedicated INTERCEPT Blood System for the inactivation of harmful agents in red blood cell components. Furthermore, Cerus markets an INTERCEPT Blood System for Cryoprecipitation, which leverages its plasma technology to produce two key pathogen-reduced blood products: a cryoprecipitated fibrinogen complex for treating and controlling bleeding, particularly massive hemorrhages stemming from fibrinogen deficiency, and pathogen-reduced, cryoprecipitate-reduced plasma. Cerus distributes these platelet and plasma systems globally through a combination of its direct sales force and an extensive network of distributors, reaching markets in North America, Europe, the Commonwealth of Independent States, the Middle East, and Latin America. Established in 1991, Cerus Corporation maintains its corporate headquarters in Concord, California.

Key metrics

Market cap

$522.35M

P/E (TTM)

-51.74

EPS (TTM)

$-0.05

Beta

1.77

Dividend yield

0.00%

Revenue / share

$1.10

50-day avg

$2.83

200-day avg

$2.35

52-week high

$3.47

52-week low

$1.17

CEO

Vivek K. Jayaraman

ETFs linked to CERS

Broad-market and Healthcare sector ETFs an investor holding Cerus is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how CERS fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze CERS in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Cerus?: Cerus trades under the ticker CERS on NASDAQ.
Which exchange is CERS listed on?: CERS is listed on NASDAQ.
What sector does Cerus operate in?: Cerus is classified in the Healthcare sector (Medical - Devices industry).
How can PortView help analyze CERS in a portfolio?: PortView shows CERS's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.